首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparison of D0870 a new triazole antifungal agent to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.
【2h】

Comparison of D0870 a new triazole antifungal agent to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.

机译:通过体外试验比较了新型三唑类抗真菌药D0870与氟康唑对白色念珠菌细胞色素P-450的抑制作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

D0870 was 12 to 15 times more active than fluconazole in experiments to determine the MIC for growth arrest for two isolates of Candida albicans. A biochemical comparison of in vitro sterol biosynthesis in cell extracts showed only a twofold superiority of D0870 over fluconazole. A large differentiation (10-fold) in 50% saturating concentrations obtained by examining the binding of the azoles to microsomal P-450 was observed in a type II binding spectrophotometric assay, possibly reflecting the differential affinity for more than one P-450 enzyme. Additional mechanisms besides affinity for the target enzyme sterol 14 alpha-demethylase, such as differential intracellular accumulation of drug, may contribute to the differences in antifungal activity.
机译:在确定两个白色念珠菌分离株生长抑制的MIC的实验中,D0870的活性是氟康唑的12至15倍。细胞提取物中体外固醇生物合成的生化比较显示,D0870仅比氟康唑优越两倍。在II型结合分光光度法中观察到通过检查唑与微粒体P-450的结合获得的50%饱和浓度有很大的差异(10倍),这可能反映了对一种以上P-450酶的差异亲和力。除了对靶酶固醇14α-脱甲基酶的亲和力外,其他机制,例如药物在细胞内的差异积累,可能会导致抗真菌活性的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号